Novel genes for QTc interval. How much heritability is explained, and how much is left to find?

Genome Medicine

Volumn 2, Issue 5, 2010, Pages

  Jamshidi, Yalda ^a,b   Nolte, Ilja M ^c   Spector, Timothy D ^b   Snieder, Harold ^b,c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; ELECTROCARDIOGRAM; ENVIRONMENTAL FACTOR; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HEREDITY; HERITABILITY; HUMAN; LONG QT SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SHORT QT SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78751694014     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm156     Document Type: Review

References (53)

1. Kobza R, Roos M, Niggli B, Abacherli R, Lupi GA, Frey F, Schmid JJ, Erne P. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm 2009, 6:652-657. 10.1016/j.hrthm.2009.01.009, 19303371.
2. Anttonen O, Junttila MJ, Rissanen H, Reunanen A, Viitasalo M, Huikuri HV. Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 2007, 116:714-720. 10.1161/CIRCULATIONAHA.106.676551, 17679619.
3. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is 'normal'. J Cardiovasc Electrophysiol 2006, 17:333-336. 10.1111/j.1540-8167.2006.00408.x, 16643414.
4. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: a prospective international study. Circulation 1985, 71:17-21.
5. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991, 84:1136-1144.
6. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richiardi E, Borggrefe M. Short QT Syndrome: a familial cause of sudden death. Circulation 2003, 108:965-970. 10.1161/01.CIR.0000085071.28695.C4, 12925462.
7. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978, 57:1074-1077.
8. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J 1993, 70:43-48. 10.1136/hrt.70.1.43, 1025227, 8037997.
9. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991, 84:1516-1523.
10. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000, 21:1216-1231. 10.1053/euhj.2000.2249, 10924311.
11. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004, 350:1013-1022. 10.1056/NEJMra032426, 14999113.
12. Mutikainen S, Ortega-Alonso A, Alen M, Kaprio J, Karjalainen J, Rantanen T, Kujala UM. Genetic influences on resting electrocardiographic variables in older women: a twin study. Ann Noninvasive Electrocardiol 2009, 14:57-64. 10.1111/j.1542-474X.2008.00273.x, 19149794.
13. Newton-Cheh C, Larson MG, Corey DC, Benjamin EJ, Herbert AG, Levy D, D'Agostino RB, O'Donnell CJ. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm 2005, 2:277-284. 10.1016/j.hrthm.2004.11.009, 15851319.
14. Russell MW, Law I, Sholinsky P, Fabsitz RR. Heritability of ECG measurements in adult male twins. J Electrocardiol 1998, 30(Suppl):64-68. 10.1016/S0022-0736(98)80034-4, 9535482.
15. Dalageorgou C, Ge D, Jamshidi Y, Nolte IM, Riese H, Savelieva I, Carter ND, Spector TD, Snieder H. Heritability of QT interval: how much is explained by genes for resting heart rate?. J Cardiovasc Electrophysiol 2008, 19:386-391. 10.1111/j.1540-8167.2007.01030.x, 18031506.
16. Pietila E, Fodstad H, Niskasaari E, Laitinen PP, Swan H, Savolainen M, Kesaniemi YA, Kontula K, Huikuri HV. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol 2002, 40:511-514. 10.1016/S0735-1097(02)01979-4, 12142119.
17. Newton-Cheh C, Guo CY, Larson MG, Musone SL, Surti A, Camargo AL, Drake JA, Benjamin EJ, Levy D, D'Agostino RB, Hirschhorn JN, O'Donnell CJ. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 2007, 116:1128-1136. 10.1161/CIRCULATIONAHA.107.710780, 17709632.
18. Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, Illig T, Akyol M, Huth C, Schopfer-Wendels A, Kuch B, Steinbeck G, Holle R, Näbauer M, Wichmann HE, Meitinger T, Kääb S. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res 2005, 96:693-701. 10.1161/01.RES.0000161077.53751.e6, 15746444.
19. Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, Luft FC, Schunkert H, Wilde AA. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 2003, 59:27-36. 10.1016/S0008-6363(03)00342-0, 12829173.
20. Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, Tichet J, Tiret L, Balkau B, Guicheney P. Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 2007, 15:974-979. 10.1038/sj.ejhg.5201866, 2234597, 17534376.
21. Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, Guicheney P. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet 2005, 13:1213-1222. 10.1038/sj.ejhg.5201489, 16132053.
22. Donnelly P. Progress and challenges in genome-wide association studies in humans. Nature 2008, 456:728-731. 10.1038/nature07631, 19079049.
23. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O'Donnell CJ, Hirschhorn JN, Kääb S, Spooner PM, Meitinger T, Chakravarti A. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006, 38:644-651. 10.1038/ng1790, 16648850.
24. Nolte IM, Wallace C, Newhouse SJ, Waggott D, Fu J, Soranzo N, Gwilliam R, Deloukas P, Savelieva I, Zheng D, Dalageorgou C, Farrall M, Samani NJ, Connell J, Brown M, Dominiczak A, Lathrop M, Zeggini E, Wain LV, , Newton-Cheh C, Eijgelsheim M, Rice K, de Bakker PI, , Pfeufer A, Sanna S, Arking DE, , Asselbergs FW, Spector TD, Carter ND, Jeffery S, et al. for the Wellcome Trust Case Control Consortium, DCCT/EDIC Research Group, for the QTGEN consortium, for the QTSCD consortium Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS ONE 2009, 4:e6138. 10.1371/journal.pone.0006138, 2704957, 19587794, for the Wellcome Trust Case Control Consortium, DCCT/EDIC Research Group, for the QTGEN consortium, for the QTSCD consortium.
25. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, Bis JC, Marciante K, Rivadeneira F, Noseworthy PA, Sotoodehnia N, Smith NL, Rotter JI, Kors JA, Witteman JC, Hofman A, Heckbert SR, O'Donnell CJ, Uitterlinden AG, Psaty BM, Lumley T, Larson MG, Stricker BH. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009, 41:399-406. 10.1038/ng.364, 2701449, 19305408.
26. Pfeufer A, Sanna S, Arking DE, Muller M, Gateva V, Fuchsberger C, Ehret GB, Orru M, Pattaro C, Kottgen A, Perz S, Usala G, Barbalic M, Li M, Pütz B, Scuteri A, Prineas RJ, Sinner MF, Gieger C, Najjar SS, Kao WH, Mühleisen TW, Dei M, Happle C, Möhlenkamp S, Crisponi L, Erbel R, Jöckel KH, Naitza S, Steinbeck G, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009, 41:407-414. 10.1038/ng.362, 2976045, 19305409.
27. Raitakari OT, Blom-Nyholm J, Koskinen TA, Kahonen M, Viikari JS, Lehtimaki T. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study. Ann Med 2009, 41:144-151. 10.1080/07853890802392529, 18785031.
28. Eijgelsheim M, Aarnoudse AL, Rivadeneira F, Kors JA, Witteman JC, Hofman A, van Duijn CM, Uitterlinden AG, Stricker BH. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration. Hum Mol Genet 2009, 18:347-357. 10.1093/hmg/ddn341, 18927126.
29. Tobin MD, Kahonen M, Braund P, Nieminen T, Hajat C, Tomaszewski M, Viik J, Lehtinen R, Ng GA, Macfarlane PW, Burton PR, Lehtimäki T, Samani NJ. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int J Epidemiol 2008, 37:1132-1141. 10.1093/ije/dyn091, 18511491.
30. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 2008, 57:1108-1114. 10.2337/db07-1365, 18235038.
31. Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, Uitterlinden AG, Witteman JC, Stricker BH. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007, 116:10-16. 10.1161/CIRCULATIONAHA.106.676783, 17576865.
32. Post W, Shen H, Damcott C, Arking DE, Kao WH, Sack PA, Ryan KA, Chakravarti A, Mitchell BD, Shuldiner AR. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish. Hum Hered 2007, 64:214-219. 10.1159/000103630, 2880727, 17565224.
33. Eijgelsheim M, Newton-Cheh C, Aarnoudse AL, van NC, Witteman JC, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study. Hum Mol Genet 2009, 18:4213-4218. 10.1093/hmg/ddp356, 2758139, 19643915.
34. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, Bishe B, Doan BQ, Boerwinkle E, Psaty BM, Tomaselli GF, Coresh J, Siscovick DS, Marbán E, Spooner PM, Burke GL, Chakravarti A. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 2009, 119:940-951. 10.1161/CIRCULATIONAHA.108.791723, 2782762, 19204306.
35. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, Greenberg DA, Schwartz PJ, George AL. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 2009, 120:1657-1663. 10.1161/CIRCULATIONAHA.109.879643, 2783481, 19822806.
36. Milan DJ, Kim AM, Winterfield JR, Jones IL, Pfeufer A, Sanna S, Arking DE, Amsterdam AH, Sabeh KM, Mably JD, Rosenbaum DS, Peterson RT, Chakravarti A, Kääb S, Roden DM, MacRae CA. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 2009, 120:553-559. 10.1161/CIRCULATIONAHA.108.821082, 2771327, 19652097.
37. Qu X, Jia H, Garrity DM, Tompkins K, Batts L, Appel B, Zhong TP, Baldwin HS. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 2008, 317:486-496. 10.1016/j.ydbio.2008.02.044, 2800102, 18407257.
38. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statististics and Probability: 21 June to 21 July 1965 1967, 1:221-233. Berkeley. Berkeley: University of California Press.
39. White H. Maximum likelihood estimation of misspecified models. Econometrica 1982, 50:1-26.
40. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008, 299:1335-1344. 10.1001/jama.299.11.1335, 18349094.
41. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701. 10.1038/ng.f.136, 2527050, 18509313.
42. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517. 10.1126/science.273.5281.1516, 8801636.
43. Nolte IM, McCaffery JM, Snieder H. Candidate gene and genome-wide association studies in behavioral medicine. Handbook of Behavioral Medicine: Methods and Applications 2010, New York: Springer, Steptoe A.
44. 1000 Genomes. A Deep Catalog of Human Genetic Variation. , http://www.1000genomes.org
45. Personal Genome Project. , http://www.personalgenomes.org
46. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, O'Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008, 40:395-402. 10.1038/ng.102, 2673512, 18311140.
47. Trynka G, Zhernakova A, Romanos J, Franke L, Hunt KA, Turner G, Bruinenberg M, Heap GA, Platteel M, Ryan AW, de Kovel C, Holmes GK, Howdle PD, Walters JR, Sanders DS, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, Kelleher D, Barisani D, Bardella MT, McManus R, van Heel DA, Wijmenga C. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 2009, 58:1078-1083. 10.1136/gut.2008.169052, 19240061.
48. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008, 9:403-433. 10.1146/annurev.genom.9.081307.164258, 2953791, 18593304.
49. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, Jones CG, Zaitlen NA, Varilo T, Kaakinen M, Sovio U, Ruokonen A, Laitinen J, Jakkula E, Coin L, Hoggart C, Collins A, Turunen H, Gabriel S, Elliot P, McCarthy MI, Daly MJ, Järvelin MR, Freimer NB, Peltonen L. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46. 10.1038/ng.271, 2687077, 19060910.
50. van Noord C, Aarnoudse AJ, Eijgelsheim M, Sturkenboom MC, Straus SM, Hofman A, Kors JA, Newton-Cheh C, Witteman JC, Stricker BH. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation. Pharmacogenet Genomics 2009, 19:260-266. 10.1097/FPC.0b013e328324e556, 19247217.
51. Aulchenko YS, Struchalin MV, Belonogova NM, Axenovich TI, Weedon MN, Hofman A, Uitterlinden AG, Kayser M, Oostra BA, van Duijn CM, Janssens AC, Borodin PM. Predicting human height by Victorian and genomic methods. Eur J Hum Genet 2009, 17:1070-1075. 10.1038/ejhg.2009.5, 19223933.
52. Maher B. Personal genomes: the case of the missing heritability. Nature 2008, 456:18-21. 10.1038/456018a, 18987709.
53. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753. 10.1038/nature08494, 2831613, 19812666.